HAE WON LEE: Open Payments
NPI 1568931913 · TEMPLE HILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 87 payments from 12 companies in 2025. Trend: 2023 $1,262 · 2024 $1,419 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $317 |
| Alkermes, Inc. | 15 | $255 |
| Neurocrine BioSciences, Inc. | 8 | $255 |
| ABBVIE INC. | 10 | $222 |
| Otsuka America Pharmaceutical, Inc. | 6 | $150 |
| Vanda Pharmaceuticals Inc. | 11 | $142 |
| Teva Pharmaceuticals USA, Inc. | 7 | $137 |
| Lundbeck LLC | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
Products named: CAPLYTA, ARISTADA, INGREZZA, VRAYLAR, REXULTI, UZEDY, ABILIFY ASIMTUFII, HETLIOZ.
Industry payments across MD — which companies pay providers there.
